نتائج البحث - "van Raalte, Daniel H"

1

دورية أكاديمية

Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes:A randomized cross-over clinical study

المؤلفون: van der Aart-van der Beek, Annemarie B., Apperloo, Ellen, Jongs, Niels, Rouw, Dennis B., Sjöström, C. David, Friedli, Iris, Johansson, Lars, van Raalte, Daniël H., Hoogenberg, Klaas, Heerspink, Hiddo J.L.

المصدر: van der Aart-van der Beek , A B , Apperloo , E , Jongs , N , Rouw , D B , Sjöström , C D , Friedli , I , Johansson , L , van Raalte , D H , Hoogenberg , K & Heerspink , H J L 2023 , ' Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes : A randomized cross-over clinical study ' , Diabetes, Obesity and Metabolism , vol. 25 , no. 6 , pp. 1758-1768 . https://doi.org/10.1111/dom.15033Test

مصطلحات موضوعية: albuminuria, chronic kidney disease, dapagliflozin, exenatide, SGLT2

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/7c3985b7-8d7e-4ef7-b41e-a555fcf6eca8Test

الإتاحة: https://doi.org/10.1111/dom.15033Test
https://hdl.handle.net/11370/7c3985b7-8d7e-4ef7-b41e-a555fcf6eca8Test
https://research.rug.nl/en/publications/7c3985b7-8d7e-4ef7-b41e-a555fcf6eca8Test
https://pure.rug.nl/ws/files/916846721/Diabetes_Obesity_Metabolism_-_2023_-_Aart_van_der_Beek_-_Albuminuria_lowering_effect_of_dapagliflozin_exenatide_and_their.pdfTest
http://www.scopus.com/inward/record.url?scp=85150613740&partnerID=8YFLogxKTest

View record in BASE

2

دورية أكاديمية

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes

المؤلفون: van der Hoek, Sjoukje, Koomen, Jeroen V., van Bommel, Erik J. M., Mosterd, Charlotte M., Scholtes, Rosalie A., Hesp, Anne C., Stevens, Jasper, van Raalte, Daniel H., Heerspink, Hiddo J. L.

المصدر: van der Hoek , S , Koomen , J V , van Bommel , E J M , Mosterd , C M , Scholtes , R A , Hesp , A C , Stevens , J , van Raalte , D H & Heerspink , H J L 2023 , ' Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes ' , Journal of personalized medicine , vol. 13 , no. 5 , 747 . https://doi.org/10.3390/jpm13050747Test

مصطلحات موضوعية: SGLT2 inhibitors, dapagliflozin, empagliflozin, pharmacokinetics, pharmacodynamics, renal hemodynamics, type 2 diabetes, response variability

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/c4f1d3a9-c8fd-4a5a-add1-4430dc2e29a8Test

الإتاحة: https://doi.org/10.3390/jpm13050747Test
https://hdl.handle.net/11370/c4f1d3a9-c8fd-4a5a-add1-4430dc2e29a8Test
https://research.rug.nl/en/publications/c4f1d3a9-c8fd-4a5a-add1-4430dc2e29a8Test
https://pure.rug.nl/ws/files/667445056/jpm_13_00747_v2.pdfTest

View record in BASE

3

دورية أكاديمية

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes:Results from DAPASALT and DIAMOND

المؤلفون: Sen, Taha, Scholtes, Rosalie, Greasley, Peter J., Cherney, David Z. I., Dekkers, Claire C. J., Vervloet, Marc, Danser, Alexander H. J., Barbour, Sean J., Karlsson, Cecilia, Hammarstedt, Ann, Li, Qiang, Laverman, Gozewijn D., Bjornstad, Petter, van Raalte, Daniel H., Heerspink, Hiddo J. L.

المصدر: Sen , T , Scholtes , R , Greasley , P J , Cherney , D Z I , Dekkers , C C J , Vervloet , M , Danser , A H J , Barbour , S J , Karlsson , C , Hammarstedt , A , Li , Q , Laverman , G D , Bjornstad , P , van Raalte , D H & Heerspink , H J L 2022 , ' Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes : Results from DAPASALT and DIAMOND ' ....

مصطلحات موضوعية: adaptive response, dapagliflozin, kidney, SGLT2 inhibitor, TYPE-2, EMPAGLIFLOZIN, CANAGLIFLOZIN

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/8e398cd9-4073-40ac-b29a-8f0b19592d95Test

الإتاحة: https://doi.org/10.1111/dom.14729Test
https://hdl.handle.net/11370/8e398cd9-4073-40ac-b29a-8f0b19592d95Test
https://research.rug.nl/en/publications/8e398cd9-4073-40ac-b29a-8f0b19592d95Test
https://pure.rug.nl/ws/files/224601741/Diabetes_Obesity_Metabolism_2022_Sen_Effects_of_dapagliflozin_on_volume_status_and_systemic_haemodynamics_in_patients.pdfTest

View record in BASE

4

دورية أكاديمية

Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake:An analysis of three randomized controlled trials

المؤلفون: van der Aart-van der Beek, Annemarie B., Cherney, David, Laverman, Gozewijn D., Stefansson, Bergur, van Raalte, Daniel H., Hoogenberg, Klaas, Reyner, Daniel, Li, Qiang, Di Tanna, Gian Luca, Greasley, Peter J., Heerspink, Hiddo J.L.

المصدر: van der Aart-van der Beek , A B , Cherney , D , Laverman , G D , Stefansson , B , van Raalte , D H , Hoogenberg , K , Reyner , D , Li , Q , Di Tanna , G L , Greasley , P J & Heerspink , H J L 2021 , ' Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake : An analysis of three randomized controlled trials ' , Diabetes, Obesity and Metabolism , vol. 23 , no. 8 , pp. 1961-1967 . https://doi.org/10.1111/dom.14411Test

مصطلحات موضوعية: dapagliflozin, diabetic nephropathy, SGLT2 inhibitor, type 2 diabetes

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/5f51963a-e738-4e79-ac44-2307d1b7774cTest

الإتاحة: https://doi.org/10.1111/dom.14411Test
https://hdl.handle.net/11370/5f51963a-e738-4e79-ac44-2307d1b7774cTest
https://research.rug.nl/en/publications/5f51963a-e738-4e79-ac44-2307d1b7774cTest
https://pure.rug.nl/ws/files/619624034/Renal_haemodynamic_response_to_sodium_glucose.pdfTest

View record in BASE

5

دورية أكاديمية

Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes:A prespecified secondary analysis of a randomized controlled clinical trial

المؤلفون: van Ruiten, Charlotte C., van der Aart-van der Beek, Annemarie B., IJzerman, Richard G., Nieuwdorp, Max, Hoogenberg, Klaas, van Raalte, Daniël H., Heerspink, Hiddo J.L.

المصدر: van Ruiten , C C , van der Aart-van der Beek , A B , IJzerman , R G , Nieuwdorp , M , Hoogenberg , K , van Raalte , D H & Heerspink , H J L 2021 , ' Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes : A prespecified secondary analysis of a randomized controlled clinical trial ' , Diabetes, Obesity and Metabolism , vol. 23 , no. 8 , pp. 1851-1858 . https://doi.org/10.1111/dom.14410Test

مصطلحات موضوعية: dapagliflozin, diabetic kidney disease, exenatide, GLP-1RA, glucagon-like peptide-1 receptor agonists, SGLT2 inhibitors

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/59bdca93-36c4-452f-9139-f7df36899868Test

الإتاحة: https://doi.org/10.1111/dom.14410Test
https://hdl.handle.net/11370/59bdca93-36c4-452f-9139-f7df36899868Test
https://research.rug.nl/en/publications/59bdca93-36c4-452f-9139-f7df36899868Test
https://pure.rug.nl/ws/files/613192052/Diabetes_Obesity_Metabolism_2021_Ruiten_Effect_of_exenatide_twice_daily_and_dapagliflozin_alone_and_in_combination_.pdfTest

View record in BASE

6

دورية أكاديمية

The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart Failure

المؤلفون: Bjornstad, Petter, Greasley, Peter J., Wheeler, David C., Chertow, Glenn M., Langkilde, Anna Maria, Heerspink, Hiddo J. L., Van Raalte, DanieL H.

المصدر: Bjornstad , P , Greasley , P J , Wheeler , D C , Chertow , G M , Langkilde , A M , Heerspink , H J L & Van Raalte , D H 2021 , ' The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart Failure ' , Journal of Cardiac Failure , vol. 27 , no. 12 , pp. 1447-1455 . https://doi.org/10.1016/j.cardfail.2021.07.003Test

مصطلحات موضوعية: Heart failure, natriuresis, nonosmotic sodium, SGLT2 inhibitors, CARDIOVASCULAR OUTCOMES, ENDOTHELIAL GLYCOCALYX, NA+/H+ EXCHANGER, EMPAGLIFLOZIN, DAPAGLIFLOZIN, MORTALITY, MECHANISMS, RISK

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/948a0890-270b-48ea-9ed4-2e8a2935f2fcTest

الإتاحة: https://doi.org/10.1016/j.cardfail.2021.07.003Test
https://hdl.handle.net/11370/948a0890-270b-48ea-9ed4-2e8a2935f2fcTest
https://research.rug.nl/en/publications/948a0890-270b-48ea-9ed4-2e8a2935f2fcTest
https://pure.rug.nl/ws/files/202795272/The_Potential_Roles_of_Osmotic_and_Nonosmotic_Sodium_Handling_in_Mediating_the_Effects_of_Sodium_Glucose_Cotransporter_2_Inhibitors_on_Heart_Failure.pdfTest

View record in BASE

7

دورية أكاديمية

The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment:a post hoc analysis

المؤلفون: Scholtes, Rosalie A., van Raalte, Daniel H., Correa-Rotter, Ricardo, Toto, Robert D., Heerspink, Hiddo J. L., Cain, Valerie, Sjostrom, C. David, Sartipy, Peter, Stefansson, Bergur

المصدر: Scholtes , R A , van Raalte , D H , Correa-Rotter , R , Toto , R D , Heerspink , H J L , Cain , V , Sjostrom , C D , Sartipy , P & Stefansson , B 2020 , ' The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment : a post hoc analysis ' , Diabetes obesity & metabolism , vol. 22 , no. 4 , pp. 549-556 . https://doi.org/10.1111/dom.13923Test

مصطلحات موضوعية: cardiac and renal risk factors, dapagliflozin, RASi, SGLT-2 inhibitors, type 2 diabetes, INADEQUATE GLYCEMIC CONTROL, COTRANSPORTER 2 INHIBITION, DOUBLE-BLIND, CARDIOVASCULAR-DISEASE, SGLT2 INHIBITOR, KIDNEY-DISEASE, BODY-WEIGHT, MELLITUS, 24-WEEK, EMPAGLIFLOZIN